Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV) [Phase 1, Phase 2]
Phase 1/2 study update of ARO-HBV in healthy volunteers and patients with Hepatitis B, with results posted in June 2024.
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Liver Cancer Disparities in American Indian and Alaska Native Persons [Phase 2]
This clinical trial update discusses a Phase 2 study investigating liver cancer disparities affecting American Indian and Alaska Native peop…
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of TQA3810 Tablets [Phase 1]
Phase 1 clinical trial completed evaluating tolerability, safety, pharmacokinetics and pharmacodynamics of TQA3810 tablets in Chronic Hepati…
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors [Phase 3]
Phase 3 trial evaluating prophylactic antiviral therapy in patients with current or past hepatitis B infection receiving anti-cancer therapy…
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: Descriptive Analysis of Changes in Hepatitis B Markers in People Living With HIV on Injectable Therapy.
This clinical trial update provides a descriptive analysis of changes in Hepatitis B markers in people living with HIV who are on injectable…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: DEcentralize Testing, Education, and Linkage to Care by Using Electronic Best Practice Advisory for Hepatitis B (DETECT-B) [NA]
DETECT-B is a clinical trial aimed at decentralizing testing, education, and linkage to care for Hepatitis B using an electronic Best Practi…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody) [Phase 2]
A Phase 2 clinical trial is evaluating entecavir prophylaxis to prevent hepatitis B reactivation in patients with resolved hepatitis B under…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) [Phase 2]
Phase 2 trial evaluating sequential GSK3228836 and peginterferon in chronic hepatitis B has completed and results have been posted.
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance
This clinical trial update describes a retrospective observational study examining whether probiotics influence HBsAg clearance in chronic h…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: The Effect of Heart Sound and White Noise on Pain and Physiological Parameters During Hepatitis B Vaccine Injection [NA]
A clinical trial evaluating whether heart sounds and white noise can reduce pain and alter physiological responses during Hepatitis B vaccin…
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT） [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of Peg-interferon antiviral therapy for chronic hepatitis B in patients wit…
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Study to Evaluate Safety and Efficacy of ASC42 Combined With ETV and PEG-IFN α-2a in Subjects With HBV [Phase 2]
Phase 2 trial evaluating safety and efficacy of ASC42 with ETV and PEG-IFN α-2a in chronic hepatitis B completed.
-
FDA approval · 2024-03-27FDA Approved: VEMLIDY — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Vemlidy (tenofovir alafenam ide) submitted by Gilead Sciences, Inc. The document indicates a sup…
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B. [Phase 2]
Phase 2 trial investigating tenofovir in pregnant individuals to prevent mother-to-child transmission of hepatitis B; study completed.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus Infection [Phase 2]
Phase 2 trial of JNJ-73763989 with pegylated interferon alpha-2a and nucleos(t)ide analogs in chronic hepatitis B was terminated; results po…
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B [Phase 3]
A Phase 3 trial evaluating peginterferon alfa-2b combined with tenofovir disoproxil fumarate (TDF) in chronic hepatitis B has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection [Phase 2]
Phase 2 clinical trial evaluating intrahepatic and peripheral immunologic and virologic marker changes in chronic hepatitis B infection. Res…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104 [Phase 1, Phase 2]
A clinical trial evaluating the hepatitis B virus synthetic long peptide vaccine ISA104 (phases 1/2) for chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine [Phase 2]
Phase 2 trial evaluating efficacy and safety of a therapeutic Hepatitis B vaccine for chronic Hepatitis B has completed.
-
EMA approval · 2024-02-08EMA Authorised: Ambirix (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.
Ambirix has been authorised for immunization against hepatitis A and hepatitis B infections.
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531 [Phase 1]
Phase 1 study assessing safety, tolerability, pharmacokinetics and pharmacodynamics of RO7020531 in healthy volunteers and people with chron…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: UHN Inpatient Hepatitis C & B Screening [Phase 4]
A Phase 4 clinical trial update regarding inpatient screening for Hepatitis C and Hepatitis B at UHN.
-
EMA approval · 2024-02-07EMA Authorised: Twinrix Paediatric (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.
EMA authorised Twinrix Paediatric, a hepatitis A and hepatitis B combination vaccine for paediatric use.
-
EMA approval · 2024-02-07EMA Authorised: Twinrix Adult (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.
Twinrix Adult has been authorised by the EMA for hepatitis A and hepatitis B immunization.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: A Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B Vaccine [Phase 1, Phase 2]
Clinical trial updates the safety and immunogenicity of a third-generation hepatitis B vaccine across Phase 1 and Phase 2, completed.